Survival disparities and predictors in gastric cancer: a population-based study from Kazakhstan (2012–2023)
Gastric cancer in Kazakhstan shows late-stage diagnosis and poor survival. Targeted screening, earlier diagnosis, and improved management of comorbidities are essential to improve outcomes and reduce mortality.
Authors
- Sanzhar Shalekenov (ORCID: https://orcid.org/0000-0003-3400-9823)
- Abduzhappar Gaipov (ORCID: https://orcid.org/0000-0002-9844-8772)
- Altay Kerimkulov (ORCID: https://orcid.org/0000-0003-2146-5125)
- Meiram Mamlin (ORCID: https://orcid.org/0000-0002-6013-5754)
- A Manatova (ORCID: https://orcid.org/0009-0007-6460-5606)
- Zhuldyz Kuanysh (ORCID: https://orcid.org/0000-0002-9578-4236)
- Yesbolat Sakko (ORCID: https://orcid.org/0000-0002-1694-2399)
- Dinara Zharlyganova
- Aidana Rakhmankulova (ORCID: https://orcid.org/0009-0001-3119-0738)
- Zhandos Burkitbayev (ORCID: https://orcid.org/0009-0000-4859-1637)
Institutions
- National Center for Biotechnology (KZ)
- National Institute of Oncology (HU)
- National Research Center for Maternal and Child Health (KZ)
- Nazarbayev University (KZ)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-11-21
- DOI
- https://doi.org/10.3389/fonc.2025.1670082
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00